Hyaluronan and Proteoglycan Link Protein 2 (HAPLN2) (Middle Region) Peptide
Quick Overview for Hyaluronan and Proteoglycan Link Protein 2 (HAPLN2) (Middle Region) Peptide (ABIN977851)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Sequence
- LDQCDGGWLA DGSVRFPITT PRPRCGGLPD PGVRSFGFPR PQQAAYGTYC
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-HAPLN2 Antibody(ARP57560_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- HAPLN2 (Hyaluronan and Proteoglycan Link Protein 2 (HAPLN2))
-
Background
-
HAPLN2 mediates a firm binding of versican V2 to hyaluronic acid.HAPLN2 may play a pivotal role in the formation of the hyaluronan-associated matrix in the central nervous system (CNS) which facilitates neuronal conduction and general structural stabilization. HAPLN2 binds to hyaluronic acid.
Alias Symbols: BRAL1
Protein Size: 340 -
Molecular Weight
- 38 kDa
-
Gene ID
- 60484
-
NCBI Accession
- NM_021817, NP_068589
-
UniProt
- Q9GZV7
Target
-